Triptorelin acetate
|
|
|
- CAS-Nr.
- 140194-24-7
- Englisch Name:
- Triptorelin acetate
- Synonyma:
- TRIPTORELIN ACETATE;OvuGel;LHRH-A3;AY 25650;Wy 42422;Wy 42462;BIM 21003;BIM 21003C;Decapeptyl-Depot;Triptelin Acetate
- CBNumber:
- CB61106806
- Summenformel:
- C64H82N18O13.C2H4O2
- Molgewicht:
- 1371.52
- MOL-Datei:
- 140194-24-7.mol
|
Triptorelin acetate Eigenschaften
- Löslichkeit
- Aqueous Base (Slightly), Methanol (Very Slightly, Heated, Sonicated), Water (Slightly)
- Aggregatzustand
- Solid
- Farbe
- White to Off-White
- Stabilität:
- Hygroscopic
- InChIKey
- HPPONSCISKROOD-UXTGTKPXNA-N
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Achtung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H360 |
Kann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen. |
Fertility (Fruchtbarkeit) |
Kategorie 1 |
Achtung |
![GHS hazard pictograms]() src="/GHS08.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
|
Triptorelin acetate Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Triptorelin acetate (TA) is a GnRH agonist that was earlier used as a veterinary drug for a single fixed-time artificial insemination through the synchronised estrous cycle of weaned sows. The risk assessment was that the Food Safety Commission of Japan (FSCJ) concluded that TA is not likely to cause adverse effects on human health through dietary exposure. Because TA does not have genotoxicity relevant to human health and is degraded in the digestive tract, its oral bioavailability is low. TA is currently used for the treatment of central precocious puberty and assisted reproduction. Injectable TA alone or in combination with levonorgestrel intrauterine device is also used to treat endometrial atypical hyperplasia (EAH) . Combination therapy is more effective, improving patients' menstrual abnormalities, endometrial thickening and quality of life, and is safe.
Chemische Eigenschaften
White Solid
Verwenden
Synthetic peptide agonist analog of LH-RH. Triptorelin acetate is a potent agonist of LH-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Antineoplastic (hormonal). Used in the treatment of endometriosis and infertility.
Triptorelin acetate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Triptorelin acetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 152)Lieferanten
140194-24-7()Verwandte Suche:
- 6-D-Tryptophan Luteinizing HorMone-Releasing Factor (Pig) Acetate
- 6-D-Tryptophan Luteinizing HorMone-Releasing Factor (Swine) Acetate
- BIM 21003C
- Decapeptyl-Depot
- OvuGel
- Triptorelin Acetate OR Triptorelin PaMoate
- Triptelin Acetate
- Triptorelin Acetate CAS 140194-24-7 (acetate)
- Triptorelin?Acetate impurity
- Triptorelin AcetateQ: What is
Triptorelin Acetate Q: What is the CAS Number of
Triptorelin Acetate Q: What is the storage condition of
Triptorelin Acetate Q: What are the applications of
Triptorelin Acetate
- Triptorelin Acetate(acetate)
- AY 25650
- BIM 21003
- Triptorelin acetate(57773-63-4 free base)
- Wy 42422
- Wy 42462
- TRIPTORELIN ACETATE
- Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-, acetate (1:1)
- 6-D-tryptophan-Luteinizing hormone-releasing factor (swine) acetate (1:1)
- Triptorelin acetate(57773634 free base),Triptorelin acetate(57773 63 4 free base)
- Triprerelin acetate
- LHRH-A3
- 140194-24-7
- C64H82N18O13C2H4O2
- C66H86N18O15
- Pharmaceuticals
- Chiral Reagents
- Intermediates & Fine Chemicals
- Peptides
